IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Ac... (quality of life. Study background .....)

IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study

Date:3/20/2008

quality of life."

Study background

The compassionate access study is being conducted initially at M. D. Anderson and Memorial-Sloan Kettering Cancer Center in New York. Eligible patients will have a confirmed diagnosis of high grade osteosarcoma with relapsed or recurrent disease, locally or metastatic, with resectable or not completely resectable disease, or who are unable to complete recommended chemotherapy due to toxicity.

Patients enrolled in the study will receive L-MTP-PE over one hour two times a week, at least three days apart, for 12 weeks (3 months). Patients will then receive L-MTP-PE once a week for the next 24 weeks (6 months). Additionally, patients may receive other treatments in combination with L-MTP-PE.

In addition to providing access to the drug, the objectives of the study are to provide supplemental safety and tolerability data for L-MTP-PE and supplemental pharmacokinetic information in a small patient subset.

For more information about the study please visit http://www.clinicaltrials.gov.

Update on L-MTP-PE Regulatory Status

The Company recently announced that following presentation of data at an oral explanation hearing before the Committee for Medicinal Products for Human Use (CHMP), the CHMP determined in a non-binding opinion that L-MTPE-PE suggested a possible clinical benefit in terms of survival and granted the Company a clock stop, or time extension. The clock stop will allow the Company additional time to respond to all the remaining questions regarding the marketing authorization application for L-MTP-PE (MAA). The CHMP has requested clarification of the existing data in order to gain assurance about the quality of the data before drawing any final conclusions from the data presented. In addition, the Company is required to address a number of remaining questions relating to chemistry, manufacturing and controls (CMC). The Comp
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
2. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
3. BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
4. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
5. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
6. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
7. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
8. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
9. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
10. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
11. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial

Post Your Comments:

(Date:5/17/2013)... , May 17, 2013 Sony Biotechnology Inc. ... SP6800 Spectral Analyzer (SP6800). Sony will be exhibiting and ... will be held at the San Diego ... California , from May 20 - 22. ... analytical system, incorporating commercial audio-visual technologies into new and ...

(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The escalation ... proteins, is placing renewed emphasis on alternate delivery ... as a number of factors are converging to ... makers and their delivery device partners . These ... conditions, the growing trend toward self-administration for chronic ...

(Date:5/17/2013)... 2013 Atossa Genetics, Inc. (NASDAQ: ATOS ), ... Guse , Chief Financial Officer & General Counsel, will ... Thursday, May 30, 2013, in New York City ... The Company,s presentation is scheduled to begin at 3:30 p.m. ... access the webcast, go to www.atossagenetics.com . ...

Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2 Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2 Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3 Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2 Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3

[0] Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color [0] Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment [0] Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference

... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... addition of Lt. Gen. Ronald R. Blanck, DO, U.S. Army ... a federal health services consulting firm based in Falls Church, ... members. , Dr. Blanck began his military career in 1968 ...

... MORRISTOWN, N.J., Dec. 14 Watson Pharmaceuticals, Inc. (NYSE: ... professionals to help maintain the bone health of prostate cancer ... Nearly two million men are receiving ADT, a palliative treatment ... "gold therapy," can cause bone loss and increase a man,s ...

Cached Medicine Technology:Oxygen Biotherapeutics, Inc. Expands Board of Directors 2 Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2 Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3 Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4 Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5

Oxygen Biotherapeutics, Inc. Expands Board of Directors Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy

(Date:5/19/2013)... 19, 2013 Fat Burning Furnace developed ... that provides people with fat burning diet ... this Fat Burning Furnace package, people will receive the ... can download quickly. The Fat Burning Furnace manual includes ... build lean muscle mass. In addition, this book covers ...

(Date:5/19/2013)... May 19, 2013 Farming methods have ... in the ground 10,000 years ago. Most recently, the ... productivity by using genetically engineered seeds and by applying ... a backlash to these techniques due to the adverse ... and a corresponding surge in interest in organic, sustainable ...

(Date:5/19/2013)... Nevada (PRWEB) May 19, 2013 Vegas ... , is proud to announce the launch it's all ... at the MGM Grand on 5/19/2013. Consumers traveling to ... new special pricing available on VegasHotelEscapes.com's website. Travelers will ... they beat any competitors price. , Vegas Hotel Escapes ...

(Date:5/19/2013)... Exciting new Skin Brushes are available from ... practice known through the ages but is a lost ... brushing, has so many benefits for our health and ... love that circulation and lymphatic systems get a boost ... is supported through Skin Brushing." , Why is Skin ...

(Date:5/19/2013)... Buenos Aires, Argentina: Yoga classes ( clases ... Aires, Argentina by the Sivananda Yoga Vedanta Center. ... - (Barrio Norte). Classes are 90 minutes and are ... offered in a calm environment, allowing visitors to enjoy ... vegetarian food, among others. , The Yoga classes follow ...

Breaking Medicine News(10 mins):Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3 Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2 Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2

[0] Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool [0] Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics [0] VegasHotelEscapes.com Announces Special Vegas Packages For Billboard Music Awards [0] Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret [0] Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center

... NEW YORK, Nov. 9 China,s,largest drugstore chain ... Nepstar Chain Drugstore Ltd (NYSE: NPD ) ... New York Stock Exchange. Nepstar offered 20,625,000 ... at US$16.20 each. Gross proceeds from the offering,not ...

... to teach children that trains and railroad tracks,may be dangerous ... railroads,in North America, are launching Safe Crossing Week, Nov 12-18, ... of 916 people are killed and,8,300 are seriously injured in ... of 39 children aged 15 and under were killed in ...

... Funding is Critical for Research, Treatment and Disease ... ALEXANDRIA, Va., Nov. 9 The American,Diabetes Association ... Labor,HHS Appropriations bill which will help provide for ... diabetes. Nearly 21 million children and,adults are affected ...

... MD. The AUA is pleased to announce their new ... Each year, more than 60,000 people are diagnosed with ... of risk factors, including cigarette smoking and exposure to ... 1999 and the report issued today is an update ...

... rise, doctors in this weeks BMJ report three cases of ... pain. , Although rare, this condition has previously only been ... is costing the NHS up to 3bn a year, with ... and 22,000 premature deaths each year caused by problems related ...

... Preliminary Information on Recapitalizations, Asset Sales and ... Anticipated Pre-Tax Charges ... Accounting Restatement, MCLEAN, Va., Nov. 9 Sunrise Senior Living,Inc. (NYSE: ... quarter ended September 30, 2007. The Company also,provided preliminary information on recapitalizations, ...

China Nepstar Chain Drugstore (NPD) Begins Trading on NYSE Safe Crossing Week 2007 Teaches Kids How to Behave Safely Around Trains ADA Urges President Bush Not to Veto Critical Appropriations Bill AUA releases new guidelines on non-muscle invasive bladder cancer Warning for women who binge drink Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007

... is the perfect partner for growing your ... are scalable to meet your needs now ... that your Allura Xper FD20 system supports ... Openness to new technologies allows you to ...

... Lesions ,Designed for the treatment of ... is a powerful ablation-only catheter. This 9 ... was designed to provide maximum cryo performance. ... as the other cryocatheters, but its larger ...

... slices, changes the way anatomy is imaged ... VCT Series of scanners combine superior resolution ... difficult patients or procedures more routine., The ... door to new procedures while improving the ...

... on the Alpha 5 include a newly ... digital processor specifically designed for ultrasonic signals. ... reduces image speckle and enables clearer imaging ... The enhanced user confidence afforded by Alpha ...

Medicine Products:

Allura Xper FD20 for Interventional Cardiology Freezor MAX LightSpeed VCT 64-slice Scanner Prosound Alpha-5